These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30067936)

  • 1. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018.
    Brieger D; Amerena J; Attia JR; Bajorek B; Chan KH; Connell C; Freedman B; Ferguson C; Hall T; Haqqani HM; Hendriks J; Hespe CM; Hung J; Kalman JM; Sanders P; Worthington J; Yan T; Zwar NA
    Med J Aust; 2018 Oct; 209(8):356-362. PubMed ID: 30067936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation: stroke prevention in focus.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    Aust Crit Care; 2014 May; 27(2):92-8. PubMed ID: 24054541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines.
    Proietti M; Lane DA; Boriani G; Lip GYH
    Can J Cardiol; 2019 May; 35(5):619-633. PubMed ID: 31030864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for atrial fibrillation and other arrhythmias in primary care.
    Wong KC; Kok C; Marschner S; Usherwood T; Chow CK
    BMC Fam Pract; 2020 May; 21(1):79. PubMed ID: 32375662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline-Recommended Therapy in Metropolitan General Practice: The AF - SMART Study.
    Orchard J; Neubeck L; Freedman B; Li J; Webster R; Zwar N; Gallagher R; Ferguson C; Lowres N
    J Am Heart Assoc; 2019 Jan; 8(1):e010959. PubMed ID: 30590964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
    Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.
    Chiang CE; Wu TJ; Ueng KC; Chao TF; Chang KC; Wang CC; Lin YJ; Yin WH; Kuo JY; Lin WS; Tsai CT; Liu YB; Lee KT; Lin LJ; Lin LY; Wang KL; Chen YJ; Chen MC; Cheng CC; Wen MS; Chen WJ; Chen JH; Lai WT; Chiou CW; Lin JL; Yeh SJ; Chen SA
    J Formos Med Assoc; 2016 Nov; 115(11):893-952. PubMed ID: 27890386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Treatment of Atrial Fibrillation.
    Gutierrez C; Blanchard DG
    Am Fam Physician; 2016 Sep; 94(6):442-52. PubMed ID: 27637120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for your practice: Important changes in the 2014 guideline for the management of patients with atrial fibrillation.
    Littrell R; Flaker G
    Postgrad Med; 2015 Jun; 127(5):535-8. PubMed ID: 25812591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.